These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7528850)
1. Efficacy of ajmaline and propafenone in patients with accessory pathways: a prospective randomized study. Chen X; Borggrefe M; Martinez-Rubio A; Hief C; Haverkamp W; Hindricks G; Breithardt G J Cardiovasc Pharmacol; 1994 Oct; 24(4):664-9. PubMed ID: 7528850 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. Ludmer PL; McGowan NE; Antman EM; Friedman PL J Am Coll Cardiol; 1987 Jun; 9(6):1357-63. PubMed ID: 3294970 [TBL] [Abstract][Full Text] [Related]
3. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia. Hammill SC; McLaran CJ; Wood DL; Osborn MJ; Gersh BJ; Holmes DR J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724 [TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia. Rowland E; McKenna WJ; Krikler DM Am J Cardiol; 1985 Jun; 55(13 Pt 1):1513-9. PubMed ID: 3873867 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia. Manz M; Steinbeck G; Lüderitz B Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693 [TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic effects of intravenous propafenone in Wolff-Parkinson-White syndrome. Dubuc M; Kus T; Campa MA; Lambert C; Rosengarten M; Shenasa M Am Heart J; 1989 Feb; 117(2):370-6. PubMed ID: 2644795 [TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation. Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303 [TBL] [Abstract][Full Text] [Related]
8. A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome. O'Nunain S; Garratt CJ; Linker NJ; Gill J; Ward DE; Camm AJ Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):2028-34. PubMed ID: 1721219 [TBL] [Abstract][Full Text] [Related]
9. [Electrophysiological effects of intravenous propafenone for treating atrial-ventricular nodal dual pathways reentrant tachycardia]. Shi L; Qian JA; Qi WH Zhonghua Nei Ke Za Zhi; 1992 Oct; 31(10):609-10, 657. PubMed ID: 1306450 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia. Chen SA; Chiang CE; Tai CT; Lee SH; Chiou CW; Ueng KC; Wen ZC; Cheng CC; Chang MS Circulation; 1996 Jun; 93(11):2023-32. PubMed ID: 8640978 [TBL] [Abstract][Full Text] [Related]
11. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia]. Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251 [TBL] [Abstract][Full Text] [Related]
12. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367 [TBL] [Abstract][Full Text] [Related]
13. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia]. Manz M; Beermann J; Gerckens U; Lüderitz B Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226 [TBL] [Abstract][Full Text] [Related]
14. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia. Jackman WM; Friday KJ; Fitzgerald DM; Yeung-Lai-Wah JA; Lazzara R Am J Cardiol; 1988 Dec; 62(19):8L-19L. PubMed ID: 3059792 [TBL] [Abstract][Full Text] [Related]
15. [Acute effects of propafenone in patients with ventricular pre-excitation]. Maia IG; Cruz Filho F; Fagundes ML; Loyola LH; Pimenta J; Lorga AM Arq Bras Cardiol; 1993 Jul; 61(1):23-6. PubMed ID: 8285860 [TBL] [Abstract][Full Text] [Related]
16. Electrophysiological effects, efficacy and safety of intravenous propafenone in termination of atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia: a prospective non-randomized interventional study. Pintarić H; Manola S; Nossan JS; Pavlović N; Delić-Brkljacić D; Radeljić V Acta Clin Croat; 2010 Mar; 49(1):25-31. PubMed ID: 20635581 [TBL] [Abstract][Full Text] [Related]
17. Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome. Brugada P; Dassen WR; Braat S; Gorgels AP; Wellens HJ Am J Cardiol; 1983 Jul; 52(1):70-2. PubMed ID: 6858931 [TBL] [Abstract][Full Text] [Related]
18. [Injectable and oral propafenone in nodal reentry and pathways of ventricular preexcitation]. Fauchier JP; Cosnay P; Moquet B; Rouesnel P; Kapusta P; Vrancea F Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1506-14. PubMed ID: 3099684 [TBL] [Abstract][Full Text] [Related]
19. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552 [TBL] [Abstract][Full Text] [Related]
20. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia. Musto B; D'Onofrio A; Cavallaro C; Musto A Circulation; 1988 Oct; 78(4):863-9. PubMed ID: 3168194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]